US Patent Issued to BDR PHARMACEUTICALS INTERNATIONAL on July 28 for "Oral formulations of Edaravone and method of manufacturing thereof" (Indian Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,099, issued on July 28, was assigned to BDR PHARMACEUTICALS INTERNATIONAL PRIVATE Ltd. (Mumbai, India).

"Oral formulations of Edaravone and method of manufacturing thereof" was invented by Shah Dharmesh Mahendrabhai (Mumbai, India), Badiger Aravind Manappa (Panchmahals, India), Patel Bhavesh Naginbhai (Panchmahals, India), Choksi Rakshit Kentanbhai (Panchmahals, India), Patil Mayurkumar Purshot-Tambhai (Panchmahals, India), Shah Jigar Atulkumar (Panchmahals, India) and Trivedi Madhavkumar Dilipbhai (Panchmahals, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to oral suspension dosage form of Edaravone. The inventi...